What are the best ways to manage ophthalmic surgical patients on antithrombotic therapy? This article provides some guidance. The British Journal of Ophthalmology
Uncategorized
Femtosecond laser-assisted cataract surgery may provide more stable refraction at 6 months
Femtosecond laser-assisted cataract surgery with IOL implantation may induce a lower variability of anterior chamber depth over time with more stable postoperative refraction compared with conventional cataract surgery, according to a study.The prospec…
Uncategorized
Clarity Announces Educational Opportunities for Its RetCamTM and HOLOS IntraOpTM Technologies
PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc. (Clarity), a medical device company focused on the manufacture of integrated optical systems for the diagnosis and management of eye disorders, announces two upcoming educational opport…
Uncategorized
Publication Exclusive: Summer ‘thoughtlets’ on dry eye and other topics
It’s summer time. Writers and readers naturally turn to lighter fare, intellectual sangria in a red Solo cup to the winter’s Sinskey Claret in Riedel — RIP, Dr. Sinskey. Growing up in New England, whatever beach reading we might have done was bookended by the sports pages in the Boston Globe. Sportswriters taught us all how to write. Each week the great Bob Ryan would pen a Sunday column filled with little snippets of his thoughts about the state of sports and the world in general. No one with literary aspirations dreamed of writing the Great American Novel; we all just wanted to write for the Globe or Sports Illustrated. I’m no Leigh Montville or Tim Layden — heck, I may not even be Mitch Jackson or Uday Devgan — but with a nod to Bill Reynolds of the Providence Journal, here is the fulfillment of a lifelong dream.
Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics Awarded the Honor of iPSC Industry Influencer
MARLBOROUGH, Mass.–(BUSINESS WIRE)–Ocata Therapeutics, Inc. (NASDAQ:OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics has been awarded the honor of iPSC industry influencer by BioInformant, a leading research firm serving the stem cell sector. Dr. Lanza was honored both for his specific involvement in early-stage, pioneering research in the area of induced Pluripotent Stem Cells, or “iPSCs”, as we
Central visual field loss may delay driver’s ability to detect pedestrians in timely manner
Vision researchers in Boston have published the second paper of a study designed to determine if a driver who suffers from loss of central vision is able to detect pedestrians in a timely manner when driving.